Capital Grand Est is an independent private equity and venture capital management firm based in Schiltigheim, France. Founded in 2012, it invests in startups and SMEs across multiple sectors and stages of maturity in the Grand Est region of France.
56% of their portfolio is in Biotech & Life Sciences. Deal activity increased 100% year-over-year (2 deals in the last 12 months). Their most common stage is series-a (56% of deals).
Portfolio
8
Fund Size
—
Top Stage
Series A
Last 12 Mo
2
Team
Florence Trinquet-Cirilli
Partner
François Lory
Partner
Jean-François Rax
Partner
Tiphanie Maier
Investment Director
Victor CHAN
VC Investment Director
Virginie MIATH
Investment Director
Jérémy RICHARD
Directeur de participations
Marc Beekenkamp
Directeur de participations
Stéphane BECKER
Directeur Associé
Portfolio Breakdown
Stage Distribution
Sector Distribution
Investment Activity
Portfolio
| Company | Round | Amount | Date |
|---|---|---|---|
 APMONIA THERAPEUTICS | Unknown | — | Feb 2026 |
 EverZom | Unknown | — | Oct 2025 |
 Elkedonia | Seed | — | Jun 2025 |
 Keey Aerogel | Series A | — | Jan 2025 |
 Exeliom Biosciences | Series A | — | Jul 2023 |
| NNextbiotix | Series A | — | Jul 2023 |
| EExeliom Biosciences | Series A | — | Jul 2023 |
| APMONIA THERAPEUTICS | Series A | — | Feb 2022 |
 SIRFULL | Seed | $6M | — |
Top Co-Investors
Last updated: 8 November 2026